Acorda Therapeutics CEO Ron Cohen Named BIO Chairman For 2015-2016 Term
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that President and Chief Executive Officer Ron Cohen, M.D, has been elected as the Chair of the Biotechnology Industry Organization (BIO) Board of Directors for the 2015-2016 term. He will also serve as the Chairman of the Health Section Governing Board.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.